Yukio Kobayashi

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group.

M. Narabayashi, Y. Kagami, M. Ogura, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.

Y. Ohashi, M. Narabayashi, R. Suzuki, 1997, Japanese journal of clinical oncology.

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

S. Mineishi, Y. Kanda, R. Suzuki, 2001, Bone Marrow Transplantation.

CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab.

D. Ennishi, M. Yamaguchi, S. Nakamura, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma.

Y. Matsuno, Y. Kagami, K. Tobinai, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation

S. Mineishi, M. Narabayashi, K. Tobinai, 2000, Bone Marrow Transplantation.